Biomarker commercialization tools were developed by the Biomarker Commercialization (BIC) consortium, a transnational cooperation of partners from the Baltic Sea Region (BSR) and beyond. The activities were co-financed by the European Regional Development Fund through the Interreg Baltic Sea Region Programme.
